Guillermo Juárez-Vega

Dr. Guillermo Juárez-Vega

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
KSKarina Santana
Karina Santana
JTJiram Torres-Ruiz
Jiram Torres-Ruiz
NMNancy R. Mejía-Domínguez
Nancy R. Mejía-Domínguez
BABeatriz Alcalá-Carmona
Beatriz Alcalá-Carmona
JMJOSE LUIS MARAVILLAS-MONTERO
JOSE LUIS MARAVILLAS-MONTERO
DCDaniel Carrillo
Daniel Carrillo
The coronavirus disease 2019 (COVID-19) survivors are frequently observed to present persistent symptoms constituting what has been called “post-acute COVID-19 syndrome” (PACS) or “long COVID-19”. Some clinical risk factors have been identified to be associated with PACS development; however, specific mechanisms responsible for PACS pathology remain unknown. This study investigates clinical, immunological, and metabolomic risk factors associated with post-acute COVID-19 syndrome (PACS) in 51 patients, assessed 7–19 months after acute infection. Among the participants, 62.7% were male and 37.2% were female, with an average age of 47.8 years. At the follow-up, 37.2% met the criteria for PACS, revealing significant differences in immunological and metabolomic profiles at the time of acute infection. Patients with PACS were characterized by elevated levels of mature low-density granulocytes (LDGs), interleukin-8 (IL-8), pyruvate, pseudouridine, and cystine. Baseline multivariate analysis showed increased pyruvate and decreased alpha tocopherol levels. At follow-up, there was a decrease in absolute B lymphocytes and an increase in non-classical monocytes and 3-hydroxyisovaleric acid levels. These findings suggest that specific immunological and metabolomic markers during acute infection can help identify patients at higher risk of developing persistent PACS.

24 November 2021 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
JRJiram Torres Ruiz
Jiram Torres Ruiz
JLJulieta Lomelín‐Gascón
Julieta Lomelín‐Gascón
Jaquelin LiraJaquelin Lira
Jaquelin Lira
APAlfredo Pérez‐Fragoso
Alfredo Pérez‐Fragoso
RTRoberto Tapia-Conyer
Roberto Tapia-Conyer
DCDaniel Carrillo
Daniel Carrillo
Click on the article title to read more.

19 September 2024 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
FLFatima Lopez-Leal
Fatima Lopez-Leal
TCTecilli Cabellos-Avelar
Tecilli Cabellos-Avelar
DCDiego A Correa-Becerril
Diego A Correa-Becerril
BJBrenda Juarez-Macias
Brenda Juarez-Macias
RCRodrigo Cervantes-Diaz
Rodrigo Cervantes-Diaz
APAraceli Perez-Lopez
Araceli Perez-Lopez
Neutrophils represent one of the host's first lines of defense against invading pathogens. However, an aberrant activation can cause damage to the host. In the case of respiratory infections with viral or bacterial pathogens, one of the most common complications is the development of acute respiratory distress syndrome (ARDS), in which neutrophil infiltration into the lung is a hallmark. Neutrophils gain expression of chemokine receptors under inflammatory conditions, and their activation can amplify the neutrophil responses. Earlier studies showed that neutrophils recruited to the lung mucosa during bacterial infection upregulate expression of CCR3 and ex vivo stimulation of CCR3 results in an increased neutrophil activation. Therefore, the modulation of effector functions or migration of neutrophils to target sites through chemokine receptors constitutes an opportunity for pharmacological intervention. We aimed to determine whether the blockade of the CCR3 using the specific antagonist SB-328437 reduces neutrophil recruitment and inflammation in the lung in the LPS-induced lung injury model and influenza infection in mice. We found that neutrophils acquire CCR3 expression in the lung alveolar space. The intraperitoneal administration of SB-328437 reduced neutrophil recruitment to the lung alveolar space and reduced tissue damage in both the LPS-induced lung injury model and influenza infection. Moreover, treatment with SB-328437 reduced the percentage of neutrophils producing TNFα and neutrophil activation in the alveolar space. Together, these data suggest that CCR3 blockade might be a pharmacological strategy to prevent the aberrant neutrophil activation that results detrimental for the host but preserves sufficient effector response to control the pathogen.

12 October 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
INItze C. Navarro-Hernandez
Itze C. Navarro-Hernandez
RRRaul F. Reyes-Huerta
Raul F. Reyes-Huerta
MCMariana Cañez-Hernández
Mariana Cañez-Hernández
JTJiram Torres-Ruiz
Jiram Torres-Ruiz
DCDaniel Carrillo
Daniel Carrillo
JMJOSE LUIS MARAVILLAS-MONTERO
JOSE LUIS MARAVILLAS-MONTERO
Systemic lupus erythematosus (SLE) is an autoimmune disorder that often leads to kidney injury, known as lupus nephritis (LN). Although renal biopsy is the primary way to diagnose LN, it is invasive and not practical for regular monitoring. As an alternative, several groups have proposed urinary extracellular vesicles (uEVs) as potential biomarkers for LN, as recent studies have shown their significance in reflecting kidney-related diseases. As a result, we developed a flow cytometry approach that allowed us to determine that LN patients exhibited a significantly higher total uEV concentration compared to SLE patients without kidney involvement. Additionally, an analysis of different-sized uEV subsets revealed that microvesicles ranging from 0.3 to 0.5 μm showed the most promise for distinguishing LN. These findings indicate that evaluating uEV concentration and size distribution could be a valuable diagnostic and monitoring tool for LN, pending further validation in more comprehensive studies.

23 December 2024 in Biomédica
Verified
Journal Article
Open access
PDF file
UPUriel Pérez-Blanco
Uriel Pérez-Blanco
JGJenniffer Yissel Girón
Jenniffer Yissel Girón
GJGuillermo Juárez-Vega
Guillermo Juárez-Vega
MJMaría Jiménez
María Jiménez
CSCarlos Sánchez
Carlos Sánchez
LGLizbeth Blancas Galicia
Lizbeth Blancas Galicia
Introducción. La enfermedad granulomatosa crónica es un defecto de la fagocitosis por deficiencia de gp91phox, p22phox, p47phox, p40phox y p67phox (forma clásica). Recientemente, se describió la deficiencia de EROS y p40phox como responsables de la forma no clásica. La técnica de oxidación de la 1,2,3-dihidrorrodamina –usando como estímulo el forbol-12-miristato-13-acetato– se utiliza para el diagnóstico de la enfermedad granulomatosa crónica clásica. Sin embargo, para la detección de la oxidación mediada por EROS y p40phox, se requiere de otros estímulos como zimosán, Escherichia coli o Staphylococcus aureus.Objetivo. Estandarizar el estímulo con zimosán en la técnica de la 1,2,3-dihidrorrodamina para evaluar el estallido respiratorio del neutrófilo.Materiales y métodos. Se obtuvo sangre de cinco sujetos sanos previo consentimiento informado. Se utilizó la técnica de 1,2,3-dihidrorrodamina usando el forbol-12-miristato-13-acetato como control y diferentes cantidades de zimosán opsonizado (150, 100, 50, 20 y 10 μg). Por citometría de flujo, se obtuvo la intensidad de fluorescencia media de la rodamina 1,2,3 en las poblaciones de neutrófilos y se calculó el índice de oxidación. Se utilizaron las pruebas de Kolmogorov-Smirnov, ANOVA y el análisis post-hoc de Tukey. Se consideró un valor de p ≤ 0,05 como estadísticamente significativo.Resultados. El forbol-12-miristato-13-acetato incrementó la intensidad de la fluorescencia media de la rodamina 1,2,3 en los sujetos sanos. Entre las diferentes condiciones de zimosán probadas, la de 50 μg fue la cantidad óptima y reproducible en todos los controles por el análisis estadístico y los hallazgos citométricos.Conclusiones. Se presenta la optimización de la técnica 1,2,3-dihidrorrodamina empleando el zimosán como estímulo.

10 June 2026 in Cells
Verified
Journal Article
Open access
PDF file
DCDaniel Alberto Carrillo-Vázquez
Daniel Alberto Carrillo-Vázquez
BABeatriz Alcalá-Carmona
Beatriz Alcalá-Carmona
JMJennifer Tiaré Balderas Miranda
Jennifer Tiaré Balderas Miranda
YRYatzil Reyna-Juárez
Yatzil Reyna-Juárez
MOMaría José Ostos-Prado
María José Ostos-Prado
DCDaniel Carrillo
Daniel Carrillo
Background: Neutrophils play a role in idiopathic inflammatory myopathies (IIMs), especially in vasculopathic manifestations. While neutrophil extracellular traps (NETs) and low-density granulocytes (LDGs) have been described, the functional relevance of other subsets—such as naïve neutrophils, reverse transendothelial migration neutrophils (rTEM), myeloid-derived suppressor cells (MDSCs), and regulatory neutrophils—and their association with vasculopathy remains unknown. Objective: We aimed to characterize the phenotypic and functional profile of neutrophil subsets and their association with vasculopathic manifestations in IIM, adjusting for disease activity. Methods: We conducted a cross-sectional, single-center study including 59 IIM patients diagnosed by muscle biopsy and fulfilling 2017 ACR/EULAR criteria. Flow cytometry was used to immunophenotype myeloid subsets, and functional assays assessed phagocytosis and respiratory burst. Patients were stratified by clinical activity and presence of vasculopathy. Results: Vasculopathic patients showed expansion of LDGs (p = 0.0092), granulocytic and monocytic MDSCs expressing Arginase-1 (p = 0.0078, p = 0.0003) and PD-L1 (p = 0.0258, p = 0.0087), and rTEM neutrophils (p = 0.0775). In contrast, they exhibited a reduction in naïve neutrophils (p = 0.0004), phagocytosis (p < 0.0001) and respiratory burst (p = 0.0006). Multivariate analysis identified naïve neutrophils and activated CD177+ neutrophils as independent predictors of vasculopathy. A positive correlation between activated and naïve neutrophils were observed in patients with vasculopathic features (r = 0.43; p < 0.05). Conclusions: IIM patients with vasculopathic features display a distinct immune profile characterized by an imbalance between proinflammatory and regulatory neutrophil subsets, alongside persistent functional impairment.